Jazz Pharmaceuticals plc has announced the appointment of Renee Gala as the new President and Chief Executive Officer, effective August 11, 2025. Gala, who joined Jazz in March 2020 as Executive Vice President and Chief Financial Officer and was promoted to President and COO in October 2023, will also join the Board of Directors. She succeeds co-founder Bruce Cozadd, who will retire as CEO but remain as Chairperson of the Board. This transition is part of the company's long-term succession planning process.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via PR Newswire (Ref. ID: SF27195) on July 10, 2025, and is solely responsible for the information contained therein.